Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karen, Cromie"'
Autor:
Rob C. Oslund, Tamara Reyes-Robles, Cory H. White, Jake H. Tomlinson, Kelly A. Crotty, Edward P. Bowman, Dan Chang, Vanessa M. Peterson, Lixia Li, Silvia Frutos, Miquel Vila-Perelló, David Vlerick, Karen Cromie, David H. Perlman, Sampat Ingale, Samantha D. O’ Hara, Lee R. Roberts, Grazia Piizzi, Erik C. Hett, Daria J. Hazuda, Olugbeminiyi O. Fadeyi
Publikováno v:
Nature Chemical Biology. 18:850-858
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab69960405338ea714227347b00d561a
https://doi.org/10.1038/s41589-022-01044-0
https://doi.org/10.1038/s41589-022-01044-0
Autor:
Rob C, Oslund, Tamara, Reyes-Robles, Cory H, White, Jake H, Tomlinson, Kelly A, Crotty, Edward P, Bowman, Dan, Chang, Vanessa M, Peterson, Lixia, Li, Silvia, Frutos, Miquel, Vila-Perelló, David, Vlerick, Karen, Cromie, David H, Perlman, Sampat, Ingale, Samantha D O', Hara, Lee R, Roberts, Grazia, Piizzi, Erik C, Hett, Daria J, Hazuda, Olugbeminiyi O, Fadeyi
Publikováno v:
Nature chemical biology. 18(8)
The growing appreciation of immune cell-cell interactions within disease environments has led to extensive efforts to develop immunotherapies. However, characterizing complex cell-cell interfaces in high resolution remains challenging. Thus, technolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::81e04945968e5b1b13b1a24d9f02675b
https://pubmed.ncbi.nlm.nih.gov/35654846
https://pubmed.ncbi.nlm.nih.gov/35654846
Autor:
Grazia Piizzi, Karen Cromie, Samantha D. O’Hara, Rob C. Oslund, Kelly A. Crotty, Vanessa M. Peterson, Lee R. Roberts, Daria J. Hazuda, Cory H. White, Erik C. Hett, Tamara Reyes-Robles, David H. Perlman, Dan Chang, David Vlerick, Silvia Frutos, Olugbeminiyi O. Fadeyi, Edward P. Bowman, Jake H. Tomlinson, Miquel Vila-Perelló, Lixia Li
Cell-cell interactions drive essential biological processes critical to cell and tissue development, function, pathology, and disease outcome. The growing appreciation of immune cell interactions within disease environments has led to significant eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be94bbf6f8e3c3e1350c37ea44680a31
https://doi.org/10.1101/2021.10.04.463039
https://doi.org/10.1101/2021.10.04.463039
Publikováno v:
Current Topics in Medicinal Chemistry. 15:2543-2557
Nanobodies are therapeutic proteins derived from the variable domain (VHH) of naturally occurring heavy-chain antibodies. These VHH domains are the smallest functional fragments derived from a naturally occurring immunoglobulin. Nanobodies can be eas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1b06af81e24941cbd096d5db5325058
https://doi.org/10.2174/1568026615666150701113549
https://doi.org/10.2174/1568026615666150701113549
Autor:
Bruno Dombrecht, Hui Gao, Mohammad Zafari, Jing Li, Joost A Kolkman, Rebecca Mosher, Axelle Royo, William R. Sellers, Joseph D. Growney, Jennifer Johnson, Guizhi Yang, Heather Huet, Alwin Schuller, Lance Ostrom, Karen Cromie, Colleen Kowal, Seth Ettenberg, Michael Rugaard Jensen, Randi Isaacs, Sanela Bilic, Kris Meerschaert
Publikováno v:
mAbs. 6:1560-1570
Multiple therapeutic agonists of death receptor 5 (DR5) have been developed and are under clinical evaluation. Although these agonists demonstrate significant anti-tumor activity in preclinical models, the clinical efficacy in human cancer patients h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb700f66f45e8845f97729d4e07231c
https://doi.org/10.4161/19420862.2014.975099
https://doi.org/10.4161/19420862.2014.975099
Autor:
Karen Cromie, Sandra De Boever, Judith Baumeister, Veerle Snoeck, Sandy Jacobs, Benedikte Serruys
Publikováno v:
Toxicology Letters. 211:S43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb40fcb48740945581d9b44dc6412267
https://doi.org/10.1016/j.toxlet.2012.03.178
https://doi.org/10.1016/j.toxlet.2012.03.178
Autor:
Kirk Clark, Andrew Paul Garner, William R. Sellers, Jing Li, Sharon Li, Rajiv Chopra, Alwin Schuller, Bruno Dombrecht, Sandra Nunes, Jennifer Johnson, Heather Huet, David R. Stover, Sanela Bilic, Megan Yao, Karen Cromie, Kris Meerschaert, Seth Ettenberg, Stephen Fawell
Publikováno v:
Cancer Research. 72:3853-3853
Preferential induction of apoptosis in cancer cells has been the objective of therapeutic strategies targeting apoptotic pathways. To this end, multiple therapeutic agonists of Death Receptors 4 and 5 (DR4, DR5), have been developed and are under cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a19065a697f4ced7e922c16e86a1be8
https://doi.org/10.1158/1538-7445.am2012-3853
https://doi.org/10.1158/1538-7445.am2012-3853